The data on measles immunisation in China from 2013 to 2023 shows high immunisation rates consistently above 98.6%. In 2023, the value stood at 99.6%. The year-on-year variation fluctuated slightly, reflecting high stability with occasional minor decreases and increases. The Compound Annual Growth Rate (CAGR) over the last five years was 0.2%.
Looking ahead, forecasted data from 2024 to 2028 suggest a slight upward trend, with the immunisation rate stabilizing around 99.7% by 2028. The five-year forecast CAGR is modest at 0.02%, indicating a largely stable immunisation rate with minimal expected annual growth.
Future trends to watch for include:
- Potential impacts of new healthcare policies on immunisation rates.
- Technological advancements in vaccine delivery and tracking.
- Global health developments that may influence public health priorities.
- Public perception and compliance with immunisation programs.
